Drugs / PCLUS 3-18 MN
last change Jan 2002 re-read 3 minutes ago

PCLUS 3-18 MN

Developed for
AIDS
Investigated by
National Cancer Institute (NCI)

Trials 1

1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00001386 Jun 1994 → Jan 2002 AIDS National Cancer Institute (NCI) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PCLUS 3-18 MN ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001386 ↗
Route Subcutaneous “the volunteers will receive 6 peptide vaccines under the skin” NCT00001386 ↗